Regulatory News
Updates
New Investors
Company Presentations
17 Nov 2026
Fusion Antibodies - Holding(s) in Company
6 Nov 2026
Fusion Antibodies - Further contract with returning client
22 Oct 2026
Fusion Antibodies - Contract win
Sort by